Skip to main content
Trending storyContinuously updated

Pathos AI raises $237M Series E at $3B valuation, led by Bristol Myers Squibb

1 reports1 report sources1 hours agoUpdate

Get up to speed on this story

AI Summary

Pathos AI raised $237 million in a Series E round at a $3 billion valuation, led by Bristol Myers Squibb, with unnamed returning backers also participating. Separately, Pathos will pay Tempus $55 million over five years to license anonymized data from patients with neurological conditions.

AI-generated from reports · 1 hours agoUpdate

Latest updatesOct 24 04:02
Pathos AI raises $237M Series E at $3B valuation led by Bristol Myers Squibb

Report timeline

Follow the reports to understand different sides of the story.

Oct 24
  1. SiliconANGLETop Deals
    Pathos AI raises $237M Series E at $3B valuation led by Bristol Myers Squibb

    Pathos AI raised $237 million in a Series E round at a $3 billion valuation, led by Bristol Myers Squibb with returning backers including AstraZeneca.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing